|
|
|
Insider
Information: |
Leung Sandra |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
348,885 |
|
Indirect Shares
|
100,721 |
|
|
Direct
Value |
$13,982,246 |
|
|
Indirect Value
|
$4,054,020 |
|
|
Total
Shares |
449,606 |
|
|
Total
Value |
$18,036,267 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
7.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, General Counsel |
2024-03-10 |
347,385 |
2024-03-10 |
100,721 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,500 |
2009-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2012-03-02 |
4 |
D |
$32.59 |
$114,652 |
D/D |
(3,518) |
104,393 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2012-03-03 |
4 |
D |
$32.59 |
$56,576 |
D/D |
(1,736) |
107,449 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2012-03-04 |
4 |
D |
$32.59 |
$46,995 |
D/D |
(1,442) |
109,987 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2012-03-06 |
4 |
D |
$32.33 |
$789,757 |
D/D |
(24,428) |
138,948 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2013-03-03 |
4 |
D |
$37.15 |
$66,350 |
D/D |
(1,786) |
144,485 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2013-03-04 |
4 |
D |
$36.94 |
$54,782 |
D/D |
(1,483) |
146,982 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2013-03-07 |
4 |
D |
$37.53 |
$1,670,385 |
D/D |
(44,508) |
191,345 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2014-03-03 |
4 |
D |
$53.49 |
$3,093,220 |
D/D |
(57,828) |
252,737 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2014-03-06 |
4 |
D |
$55.56 |
$269,577 |
D/D |
(4,852) |
257,242 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2014-03-10 |
4 |
D |
$56.14 |
$206,483 |
D/D |
(3,678) |
260,656 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-02 |
4 |
D |
$62.30 |
$1,424,053 |
D/D |
(22,858) |
293,397 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-02 |
4 |
D |
$62.30 |
$409,623 |
D/D |
(6,575) |
272,171 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-06 |
4 |
D |
$65.12 |
$363,435 |
D/D |
(5,581) |
298,578 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-10 |
4 |
D |
$65.53 |
$463,101 |
D/D |
(7,067) |
305,139 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-06 |
4 |
D |
$64.71 |
$363,864 |
D/D |
(5,623) |
314,801 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(70) |
326,026 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-10 |
4 |
D |
$64.94 |
$2,064,378 |
D/D |
(31,789) |
344,507 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,227) |
407,330 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2017-03-10 |
4 |
D |
$58.32 |
$2,011,748 |
D/D |
(34,495) |
427,791 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2018-03-10 |
4 |
D |
$67.92 |
$2,352,885 |
D/D |
(34,642) |
464,585 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2019-02-28 |
4 |
D |
$51.86 |
$5,697,028 |
D/D |
(109,854) |
524,624 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2019-03-10 |
4 |
D |
$51.39 |
$1,038,335 |
D/D |
(20,205) |
546,080 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,509) |
534,266 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(298) |
555,623 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2020-03-10 |
4 |
D |
$57.93 |
$1,640,114 |
D/D |
(28,312) |
574,164 |
0 |
- |
|
133 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|